Comparative analysis of the effectiveness of abiraterone before and after docetaxel in patients with metastatic castration-resistant prostate cancer

doi:10.5306/wjco.v6.i4.64

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7116)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

466

WORD

341

HTML

3368

Figures (1-4)

496

Tables (1-3)

236

Sum=4907

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

880

Download

1328

Sum=2208

Aug 10, 2015 (publication date) through Jan 14, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Clin Oncol. Aug 10, 2015; 6(4): 64-72
Published online Aug 10, 2015. doi: 10.5306/wjco.v6.i4.64

Full Size Figure Download Figure

Figure 1 Selection of randomized controlled trials included in the meta-analysis. RCTs: Randomized controlled trials.

Citation: Shameem R, Hamid MS, Xu KY, Wu S. Comparative analysis of the effectiveness of abiraterone before and after docetaxel in patients with metastatic castration-resistant prostate cancer. World J Clin Oncol 2015; 6(4): 64-72
URL: https://www.wjgnet.com/2218-4333/full/v6/i4/64.htm
DOI: https://dx.doi.org/10.5306/wjco.v6.i4.64